JCB, Volume 12, Number 2, 2006 Editorial Vol.12 No. 2 (2006) Editorial: Much ado about nothing Simon Bright   Article Vol.12 No. 2 (2006) Downstream and into deep biology: Evolving business models in 'top tier' genomics companies Harry Rothman Genomics companies are changing their business models and some have moved beyond drug discovery into drug development. The authors' analysis of genomics companies' busi Article Vol.12 No. 2 (2006) The new tax rules for university spin-outs: An answer to all the problems? Alison Hughes This paper gives an overview of the potential tax position for an academic participating in a university spin-out following the new legislation in the UK Finance Act 20 Article Vol.12 No. 2 (2006) The convergence of biotechnology and nanotechnology: Why here, why now? Tom C Thomas Nanotechnology offers a promise to revolutionise the life sciences because it equips biologists with tools and materials that can interact directly with the biomolecule Article Vol.12 No. 2 (2006) The development of the South African biotech sector Britt Akermann Like many other countries around the world South Africa is keen to develop its biotech capabilities. A vibrant biotech sector could have economic benefits and could als Article Vol.12 No. 2 (2006) Stem cell patenting Claire Baldock The patenting of embryonic stem cell-related inventions appears to be as controversial as the technology itself. The author outlines the state of play in Europe and the Article Vol.12 No. 2 (2006) The dismantling of redundant dichotomies: Biotechnology as an exemplar of university–industry collaboration Michael J Lynskey This paper suggests that the established and distinctive dualisms invoked to describe aspects of research and forms of organisation are unravelling and becoming less me Article Vol.12 No. 2 (2006) Growth drivers and resistors of the influenza market: The importance of cell culture flu Mark Belsey Following flu vaccine manufacturing and supply issues in the USA and the global threat of an avian flu pandemic, the flu market is attracting considerable interest. Thi Legal and Regulatory Updates Vol.12 No. 2 (2006) Legal and regulatory update John Wilkinson EC Directive 2001/83/EC (the 'Medicines Directive'), which governs the manufacture, marketing and distribution of medicinal products for human use, is being amended by Legal and Regulatory Updates Vol.12 No. 2 (2006) Obituary JCB Editor It is with sadness that we report the sudden death of Editorial Board member Dr Iain Cubitt in a tragic car accident on Friday 13th January 2006.
